Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-22

FDA Approved: AMPHETAMINE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original application for generic Amphetamine, enabling marketing of amphetamine as a stimulant for ADHD and narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMPHETAMINE (AMPHETAMINE)

Snippet

ORIG AP for AMPHETAMINE (AMPHETAMINE)